FiercePharma Manufacturing The FDA has kept a close eye on Chinese heparin makers ever since tainted crude heparin from China was tied to the deaths of dozens of dialysis patients in the U.S. The agency has now taken steps against a Chinese heparin maker it says is using ...
The Pharma Letter It is projected that the heparin active pharmaceutical ingredient (API) in China will achieve an additional capacity of more than 20 trillion units b...
Anesthesiology News “Currently, there is insufficient data regarding the risk of neuraxial hematoma for analgesia in conjunction with heparin administered three times daily,” noted Jackson Su, MD, assistant professor of anesthesiology and perioperative medicine at the ...
Regulatory Focus A Chinese-based manufacturer of heparin products has been sent a Warning Letter by the US Food and Drug Administration (FDA) after regulators accused the company of preventing FDA inspectors from accessing the facility earlier this year, and possibly ...
Counsel & Heal A team of researchers is set out to make Heparin - life saving blood thinner used in major surgeries - use a lot safer by developing a universal antidot...
In-PharmaTechnologist.com The resulting crude heparin will be processed into API at Pharma Action's refinement plant in Berlin, which has capacity to produce 10 tonnes...
The Biological SCENE A research team led by Jayachandran N. Kizhakkedathu of the University of British Columbia recently designed a reversal agent for heparin (Sci. Tr...
7thSpace Interactive (press release) IntroductionThere are approximately 19 million new cases of sepsis worldwide each year. Among them, more than one-quarter of patients die. We aimed to assess the effects of heparin on short term mortality in adult patients with sepsis and severe sepsis.
PR Web (press release) On September 12, Hospira, Inc. announced the recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL due to particulate matter. In light of this news, AttorneyOne, ... and more »
2 Minute Medicine Although the current standard of DVT prophylaxis for cancer patients is 6 months of low-molecular weight heparin (LMWH), residual vein thrombosis (RV...
